glp 1 inventor The GLP-1 truce Leading GLP-1 expert shares insights

The hallmark of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), leading to diminished dopamine levels in the striatum

others are more limited

Saxenda a higher-dose daily liraglutide formulation Wegovy a higher-dose weekly semaglutide formulation Zepbound the weight-loss formulation of tirzepatide These medications are typically approved for adults with obesity, or for those who are overweight with additional health conditions such as high blood pressure, abnormal cholesterol, or sleep apnoea

States often receive rebates to further reduce prices

Any side effects which become too uncomfortable to manage should be discussed with your healthcare provider to find a solution